Analytical Study for the Charge-Transfer Complexes of Rosuvastatin Calcium with π-Acceptors

被引:28
作者
Alzoman, Nourah Z. [1 ]
Sultan, Maha A. [1 ]
Maher, Hadir M. [1 ,2 ]
Alshehri, Mona M. [1 ]
Wani, Tanveer A. [1 ]
Darwish, Ibrahim A. [1 ]
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh 11451, Saudi Arabia
[2] Univ Alexandria, Dept Pharmaceut Analyt Chem, Fac Pharm, Alexandria 21521, Egypt
关键词
atherosclerosis; cholesterol; rosuvastatin calcium; charge-transfer complexes; spectrophotometry; pharmaceutical analysis; SPECTROPHOTOMETRIC DETERMINATION; ASSAY;
D O I
10.3390/molecules18077711
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Studies were carried out to investigate the charge-transfer (CT) reaction of ROS-Ca, as a n-electron donor with various pi-acceptors: tetracyanoethylene, p-chloranilic acid, 2,3-dichloro-5,6-dicyano-1,4-benzoquinone, 2,3,5,6-tetrabromo-1,4-benzoquinone, 1,3,5-trinitrobenzene, 2,3,5,6-tetrachloro-1,4-benzoquinone, 7,7,8,8-tetracyano-quinodimethane, and 2,4,7-trinitro-9-fluorenone. Different colored CT complexes were obtained. The reaction mechanism and site of interaction were determined by ultraviolet-visible spectrophotometric techniques and computational molecular modeling. The formation of the colored complexes was utilized in the development of simple, rapid and accurate spectrophotometric methods for the determination of ROS-Ca. Under the optimum reaction conditions, linear relationships with good correlation coefficients (0.9984-0.9995) were found between the absorbances and the concentrations of ROS-Ca in the range of 2-200 mu g mL(-1). The limits of detection ranged from 0.41 to 12.24 mu g mL(-1). No interference could be observed from the additives commonly present in the tablets or from the drugs that are co-formulated with ROS-Ca in its combined formulations. The methods were successfully applied to the analysis of tablets with good accuracy and precision; the recovery percentages ranged from 99.54-100.46 +/- 1.58-1.82%. The results were compared favorably with the reported method. The proposed methods are practical and valuable for routine application in quality control laboratories for determination of ROS-Ca in its bulk form and tablets.
引用
收藏
页码:7711 / 7725
页数:15
相关论文
共 34 条
[1]   High Doses of Rosuvastatin are Superior to Low Doses of Rosuvastatin Plus Fenofibrate or n-3 Fatty Acids in Mixed Dyslipidemia [J].
Agouridis, A. P. ;
Tsimihodimos, V. ;
Filippatos, T. D. ;
Tselepis, A. D. ;
Elisaf, M. S. .
LIPIDS, 2011, 46 (06) :521-528
[2]  
Ahmed S., 2011, SPECTROPHOTOMETRY PH
[3]  
[Anonymous], 2008, US STAT PHARM 24 NAT
[4]  
[Anonymous], 1989, VOG TXB PRACT ORG CH, P1442
[5]  
Chaudhari B. G., 2007, Indian Journal of Pharmaceutical Sciences, V69, P130
[6]   Rosuvastatin in the management of hyperlipidemia [J].
Cheng, JWM .
CLINICAL THERAPEUTICS, 2004, 26 (09) :1368-1387
[7]  
Cheng-Lai Angela, 2003, Heart Dis, V5, P72, DOI 10.1097/01.HDX.0000050417.89309.F8
[8]   Validated spectrophotometric and fluorimetric methods for analysis of clozapine in tablets and urine [J].
Darwish, I ;
Abdel-Wadood, H ;
Abdel-Latif, N .
ANNALI DI CHIMICA, 2005, 95 (05) :345-356
[9]  
Darwish IA, 2006, J AOAC INT, V89, P334
[10]  
Darwish IA, 2006, J AOAC INT, V89, P326